tiprankstipranks
Citius Oncology, Inc. (CTOR)
NASDAQ:CTOR
US Market
Want to see CTOR full AI Analyst Report?

Citius Oncology (CTOR) Ownership - Who Owns Citius Oncology?

132 Followers

Citius Oncology (CTOR) Ownership Overview

6.58%0.73%9.88%0.62%82.18%
9.88% Other Institutional Investors
0.62% ETFs
82.18% Public Companies and
Individual Investors
The ownership structure of Citius Oncology (CTOR) stock is a mix of institutional, retail, and individual investors. Approximately 11.23% of the company’s stock is owned by Institutional Investors, 6.58% is owned by Insiders, and 82.18% is owned by Public Companies and Individual Investors.
The ownership structure of Citius Oncology (CTOR) stock is a mix of institutional, retail, and individual investors. Approximately 10.61% of the company’s stock is owned by Institutional Investors, 6.58% is owned by Insiders, and 0.62% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,700,000Insider1.83%1,426,300
950,000Insider1.02%797,050
825,000Insider0.89%692,175
825,000Insider0.89%692,175
534,824Institution0.58%448,717
475,087Institution0.51%398,598
321,228Insider0.35%269,510
300,000Insider0.32%251,700
300,000Insider0.32%251,700
300,000Insider0.32%251,700

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
475,087Institution0.51%398,598
200,869Institution0.22%168,529

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
370,100Institution0.40%229,425
164,724Institution0.18%102,112
44,963Institution0.05%40,615

FAQ

Who Owns Citius Oncology, Inc. (CTOR)?
According to the latest TipRanks data, approximately 9.88% of the company's stock is held by institutional investors, 6.58% is held by insiders, and 82.18% is held by retail investors.
    What percentage of Citius Oncology, Inc. (CTOR) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 9.88% of Citius Oncology, Inc. (CTOR) stock is held by institutional investors.
      What percentage of Citius Oncology, Inc. (CTOR) stock is held by retail investors?
      According to the latest TipRanks data, approximately 82.18% of Citius Oncology, Inc. (CTOR) stock is held by retail investors.
        Who owns the most shares of Citius Oncology, Inc. (CTOR)?
        Leonard Mazur owns the most shares of Citius Oncology, Inc. (CTOR).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.